Science Explorer Back to mapMap
Discussion
Researcher · University of British Columbia · Canada

Megan K. Levings

Megan K. Levings publishes mostly in Immunology, Oncology and Molecular Biology, on topics such as T-cell and B-cell Immunology, Immune Cell Function and Interaction and CAR-T cell therapy research.

ORCID 0000-0002-0305-5790 OpenAlex
World rank
#86,724
of 7,710,434 ranked researchers
Rank in Canada
#2,681
of 183,316
Works
346
Citations
21k
Citations per work
60.4
h-index
71
i10-index 174Top 1.4% in Immunology
Megan K. Levings

What does Megan K. Levings research?

Megan K. Levings's work is mostly in Immunology and Microbiology (53%), Medicine (15%), Biochemistry, Genetics and Molecular Biology (14%).

Life Sciences: 231 works · 66.8% of their workImmunology and Microbiology: 183 works · 53.0% of their workImmunology: 183 works · 53.0% of their workBiochemistry, Genetics and Molecular Biology: 48 works · 13.8% of their workMolecular Biology: 25 works · 7.3% of their workGenetics: 22 works · 6.5% of their workEverything else: 63 works · 18.3% of their workHealth Sciences: 52 works · 14.9% of their workMedicine: 52 works · 14.9% of their workOncology: 28 works · 8.2% of their workSurgery: 14 works · 4.0% of their workEpidemiology: 9 works · 2.7% of their workTHEIR WORKMegan K. Levings346works
Life Sciences67%Health Sciences15%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology18353.0%
    2. Biochemistry, Genetics and Molecular Biology4813.8%
  2. Everything else6318.3%
    1. Medicine5214.9%
  1. 1Immunology53% of their works
  2. 2Oncology8% of their works
  3. 3Molecular Biology7% of their works
  4. 4Genetics6% of their works
  5. 5Surgery4% of their works
  6. 6Epidemiology3% of their works

Research topics

Which keywords describe Megan K. Levings's research?

The keywords of their largest research topics: Autoimmunity, Foxp3, TGF-ß, Natural Killer Cells, NK Cell Recognition, Cancer Immunotherapy, Immunotherapy and CAR T Cells.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Autoimmunity2192 topics
  2. Foxp31791 topic
  3. TGF-ß1791 topic
  4. NK Cell Recognition1731 topic
  5. Natural Killer Cells1731 topic
  6. Cancer Immunotherapy1082 topics
  7. Immunotherapy962 topics
  8. CAR T Cells561 topic
  9. Chimeric Antigen Receptor561 topic
  10. Dendritic Cells521 topic
  11. Immunity521 topic
  12. Genetics401 topic
  13. Type 1 Diabetes401 topic
  14. Bone Marrow Niche171 topic
  15. Hematopoietic Stem Cells171 topic
  16. Pancreatic Islets171 topic
  17. ß-Cell Dysfunction171 topic
  18. Pattern Recognition Receptors161 topic
  19. Toll-like Receptors161 topic

Where does Megan K. Levings work?

Megan K. Levings's main affiliation in the publication record is University of British Columbia, Canada.

How many publications and citations does Megan K. Levings have?

OpenAlex counts 346 works and 20,906 citations for Megan K. Levings, an h-index of 71, ranking #86,724 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Megan K. Levings. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.